Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Apr 09, 2021 12:59pm
96 Views
Post# 32967342

RE:RE:Remember that time

RE:RE:Remember that time Shorters and other obvioulsy have a lot of time to get back into this stock if they think it will go back up.

Lets say they make $3.2M for Q1 what will that do? nothing

Bottom line the ceo made an unbelievably terrible decision with this so called rollout and everyone views it as a total 180 degree plan shift hence whey we are all the way back down to where we started after the reverse split.  Its like the last year of covid revenue and working on aristotle was all for not.  Thats not how it is but thats how it appears.

There are 3 groups of people in this stock now
1. People that sold close to the top - lucky and the best group to be in.  this group is likely buying back in now as well.
2. people that didnt sell the first day, thought that might be the worst of it then lost on the second but then decided not to sell with the hopes it will recover.  These people have a massive hit to their portfolio and are pi$$ed off about it.  rightfully so.  Probably the worst spot to be in.  you have a huge loss right now and dont know what to do.  do you accept the loss and invest elsewhere to recover or do you stick it out for what will likely be another 6-9 months hoping this new plan works and hoping other companies dont blow past us and Stage is forgetten.
3. The investors groups like our one analyst brought into this company.  They are kind of at the same stage as number 2 people without such a loss though likely.  They still have the same decision to make though.  Are they not impressed with this company now, do they take there money elsewhere.  Why should they leave it with Stage. Thats the question they are asking themselves.  And what do we have to keep them here?  A drastic decrease by the analyst and a 2 page letter with Q&A.  Thats it.
<< Previous
Bullboard Posts
Next >>